On the afternoon of the 16th, at the Seoul·Gangwon Employment Training Center of the Korean Nurses Association in Jung-gu, Seoul, AstraZeneca (AZ) vaccine vials and integrated syringes were unveiled ahead of COVID-19 vaccination training for nurses. <br>[Image source=Yonhap News]

On the afternoon of the 16th, at the Seoul·Gangwon Employment Training Center of the Korean Nurses Association in Jung-gu, Seoul, AstraZeneca (AZ) vaccine vials and integrated syringes were unveiled ahead of COVID-19 vaccination training for nurses.
[Image source=Yonhap News]

View original image


[Asia Economy Reporter Jeong Dong-hoon] AstraZeneca (AZ) COVID-19 vaccinations are scheduled to begin on the 26th.


According to the Central Disease Control Headquarters as of midnight on the 20th, among the 366,959 residents and workers under 65 years old registered for vaccination at nursing hospitals, nursing facilities, and mental care and rehabilitation facilities nationwide, 344,181 people, or 93.8%, have expressed their intention to receive the AstraZeneca vaccine.



The health authorities previously pre-registered the vaccination candidates at 5,873 facilities and have been adjusting and supplementing the number of vaccine recipients by institution. The vaccination consent rate announced on this day reflects the final numbers confirmed by local health centers as of the previous day.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing